Anti-MMP7 antibody [EPR1251(2)]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(3 Publications)
Rabbit Recombinant Monoclonal MMP7 antibody. Suitable for WB, Flow Cyt (Intra) and reacts with Human samples. Cited in 3 publications.
View Alternative Names
MPSL1, PUMP1, MMP7, Matrilysin, Matrin, Matrix metalloproteinase-7, Pump-1 protease, Uterine metalloproteinase, MMP-7
- Flow Cyt (Intra)
Supplier Data
Flow Cytometry (Intracellular) - Anti-MMP7 antibody [EPR1251(2)] (AB176325)
Intracellular flow cytometric analysis of permeabilized BxPC-3 cells labeling MMP7using ab176325 at a 1/100 dilution (red) or a rabbit IgGcontrol (green).
- WB
Supplier Data
Western blot - Anti-MMP7 antibody [EPR1251(2)] (AB176325)
All lanes:
Western blot - Anti-MMP7 antibody [EPR1251(2)] (ab176325) at 1/1000 dilution
Lane 1:
Human prostate lysate at 10 µg
Lane 2:
BxPC-3 lysate at 10 µg
Lane 3:
Human colon cancer lysate at 10 µg
Predicted band size: 29 kDa
false
- WB
Collaborator
Western blot - Anti-MMP7 antibody [EPR1251(2)] (AB176325)
ab176325 was shown to react with MMP7 in wild-type A549 cells in Western blot with loss of signal observed in a MMP7 knockout cell line. Wild-type A549 and MMP7 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab176325 overnight at 4 °C at a 1/1000 dilution. Blots were incubated with secondary antibodies at 0.2 µg/mL before imaging.
This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.
All lanes:
Western blot - Anti-MMP7 antibody [EPR1251(2)] (ab176325) at 1/1000 dilution
Lane 1:
Wild-type HepG2 lysate at 30 µg
Lane 2:
MMP7 knock-out A549 lysate at 30 µg
false
Related conjugates and formulations (1)
-
Anti-MMP7 antibody [EPR1251(2)] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
MMP7 participates in wound healing embryonic development and tissue invasion processes. It does not typically form large complexes but can interact with other ECM components and inhibitors like TIMPs (tissue inhibitors of metalloproteinases). MMP7 has specific roles in regulating cellular environments by modifying the ECM and influencing the bioavailability of growth factors.
Pathways
MMP7 plays significant roles in pathways like the Wnt and MAPK signaling pathways. In the Wnt pathway MMP7 modulates the availability of bound matrix proteins influencing signaling dynamics. It interacts with proteins such as B-catenin and influences downstream gene expression. In the context of MAPK pathways MMP7 activity can lead to signal transduction changes that impact cell proliferation and migration.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (3)
Recent publications for all applications. Explore the full list and refine your search
Cancer reports (Hoboken, N.J.) 5:e1261 PubMed32761892
2020
Applications
Unspecified application
Species
Unspecified reactive species
Antioxidants & redox signaling 31:521-538 PubMed31084358
2019
Applications
Unspecified application
Species
Unspecified reactive species
Oncotarget 7:47609-47619 PubMed27356744
2016
Applications
WB
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com